Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation-Reference-Cited by-同舟云学术

Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation

Published:2019-04-16 Issue:11 Volume:29 Page:5752-5762
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Yang Zhiwen,Zou Ruhai,Zheng Yun,Qiu Jiliang,Shen Jingxian,Liao Yadi,Zhang Yuanping,Wang Chenwei,Wang Yongjin,Yuan Yichuan,Li Kai,Zuo Dinglan,He Wei,Liu Wenwu,Li Binkui,Yuan Yunfei^ORCID

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Guangzhou Science, Technology and Innovation Commission

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00330-019-06157-0.pdf

Reference33 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108

2. Yoshidome H, Takeuchi D, Kimura F et al (2011) Treatment strategy for hepatocellular carcinoma with major portal vein or inferior vena cava invasion: a single institution experience. J Am Coll Surg 212:796–803

3. Han K, Kim JH, Ko GY, Gwon DI, Sung KB (2016) Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: a comprehensive review. World J Gastroenterol 22:407–416

4. Lin DX, Zhang QY, Li X, Ye QW, Lin F, Li LL (2011) An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus. J Cancer Res Clin Oncol 137:139–149

5. Sun JX, Shi J, Li N et al (2016) Portal vein tumor thrombus is a bottleneck in the treatment of hepatocellular carcinoma. Cancer Biol Med 13:452–458

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Portal vein tumor thrombosis in hepatocellular carcinoma patients: Is it the end?;Liver Research;2024-09

2. A real-world study of tyrosine kinase inhibitors plus anti-PD-1 immunotherapy with or without chemoembolization for hepatocellular carcinoma patients with main portal vein invasion;Abdominal Radiology;2024-07-09

3. Liver resection in selective hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombosis improves prognosis;Journal of Liver Cancer;2024-03-31

4. Value of computed tomography-based lipiodol retention pattern in the assessment of hepatocellular carcinoma complete response following conventional transarterial chemoembolization;Egyptian Journal of Radiology and Nuclear Medicine;2024-01-17

5. Mapping research trends of transarterial chemoembolization for hepatocellular carcinoma from 2012 to 2021: A bibliometric analysis;World Journal of Methodology;2023-09-20